Keynote

(K3) Specialty Pharmaceutical Pipeline 2023

Friday, March 24, 2023

11:15 AM – 12:30 PM

Location: B2/3

ACPE UAN:0233-0000-23-023-L04-P | Contact Hours: 1.25 | Activity Type: Knowledge-based

Faculty(s)

Jeffrey Casberg, MS, RPh

Sr. VP of Pharmacy
IPD Analytics, LLC
Old Saybrook, CT
Leslie Fish, RPh, PharmD

VP of Pharmacy
IPD Analytics, LLC
Worcester, MA

Moderator(s)

Christina Barrington, PharmD

VP of Pharmacy Programs
Priority Health
Middleville, MI

As the specialty pharmaceutical pipeline continues to erupt, it is important to stay up-to-date on key late Phase 3 products, as well as those with pending approval dates over the next year. This pipeline session will focus on new and emerging specialty medications and their projected time to market, any potential FDA or legal delays, their potential place in therapy, and implications for managed care pharmacy.

Learning Objectives::

At the completion of this activity, participants should be able to:

Identify high-impact specialty drugs that are recently approved or likely to emerge from the pharmaceutical pipeline in the next 12 months.
Describe the mechanism of action and expected indications of promising agents in the pipeline.
Outline key Pharmacy and Therapeutics Committee considerations and cost impacts of specialty pipeline products.
Discuss FDA, legal, or current events that may impact important pipeline drug release dates or sales.